Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anne-Catherine Aubert"'
Publikováno v:
Clinica Chimica Acta. 273:89-93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfb56bd54d544d6c051d630537f12143
https://doi.org/10.1016/s0009-8981(98)00029-1
https://doi.org/10.1016/s0009-8981(98)00029-1
Autor:
François Borgeat, Didier Camus, Nadine Kaufmann, Jacques Besson, Charles Bonsack, Chin B. Eap, Michel Gillet, Pierre Baumann, Anne Catherine Aubert
Publikováno v:
Addictive behaviors. 31(7)
Background Co-morbid substance misuse is common in psychiatric disorders, has potentially severe adverse consequences and may be frequently undetected. Aims To measure the prevalence of substance use among patients admitted to a Swiss psychiatric hos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b86fc26ef241e58b4e9afe6fb77d69a
https://pubmed.ncbi.nlm.nih.gov/16137835
https://pubmed.ncbi.nlm.nih.gov/16137835
Autor:
Gabriela Bleiber, Amalio Telenti, Thierry Buclin, Gianni Cucchia, Kerry Powell Golay, Daniele Fabio Zullino, Reinhold Kerb, Elisabeth Hustert, Pierre Baumann, Anne-Catherine Aubert, Chin B. Eap
Publikováno v:
European journal of clinical pharmacology, vol. 60, no. 4, pp. 237-46
OBJECTIVE: We investigated whether the oral administration of a low dose (75 micro g) of midazolam, a CYP3A probe, can be used to measure the in vivo CYP3A activity. METHODS: Plasma concentrations of midazolam, 1'OH-midazolam and 4'OH-midazolam were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be1f1dd8e4f6ce8146c45ab3933a39a
https://doi.org/10.1007/s00228-004-0762-z
https://doi.org/10.1007/s00228-004-0762-z
Autor:
Thierry Buclin, Chin B. Eap, Pierre Baumann, Kerry Powell Golay, Gabriela Bleiber, Amalio Telenti, Reinhold Kerb, Anne-Catherine Aubert, Elisabeth Hustert
Publikováno v:
European journal of clinical pharmacology, vol. 60, no. 4, pp. 231-236
OBJECTIVE: We investigated whether differences in pharmacokinetics of midazolam, a CYP3A probe, could be demonstrated between subjects with different CYP3A4 and CYP3A5 genotypes. METHODS: Plasma concentrations of midazolam, and of total (conjugated +
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30ed1f6970dca2baa3830a027fe4e75d
https://serval.unil.ch/notice/serval:BIB_C414875FF528
https://serval.unil.ch/notice/serval:BIB_C414875FF528
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 11(1)
The metabolism of the antidepressant citalopram (CIT) by monoamine oxidase B (MAO-B) was studied in vitro. In incubations with blood of nine healthy volunteers R-(P=0.015) and S-(P=0.0034) CIT propionic acid (CITPROP) production was correlated with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6109a27ba4bc0ef840cc543c8fcbe201
https://pubmed.ncbi.nlm.nih.gov/11226815
https://pubmed.ncbi.nlm.nih.gov/11226815
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 5(1)
After 9 days of risperidone therapy (2-6 mg/day), a 24-year-old schizophrenic female patient developed a leucopenia with neutropenia1000/mm3. A few days after starting the neuroleptic treatment, she suffered from a cold, without fever. All immunologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0307c59580a2d178e26eecefb4733d67
https://pubmed.ncbi.nlm.nih.gov/7542050
https://pubmed.ncbi.nlm.nih.gov/7542050